Aptus Pharma shareholders and shareholding pattern
BSE: 544529Pharmaceuticals & BiotechnologySmall Cap
Aptus Pharma Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2025
Last close ₹472.10down ₹9.60 (1.99%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹481.70.
27 Oct: open ₹472.10, high ₹472.10, low ₹472.10
52-week range of traded prices to 27 Oct 2026
₹48.10Low, 27 Oct 2025₹510.90High, 23 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹810 Cr2,265th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 101.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 28.49
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 31.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 11,600
Aptus Pharma's shareholding pattern for Sep 2026, filed on 10 Oct 2026, with every filing from Dec 2025: who owns its shares by group and its promoters by name.
Who owns Aptus Pharma, filing by filing
Per cent of the company's shares.
30 Sep 2026 filing
- Promoters72.89%
- Individuals and others27.11%
Shareholding pattern, per cent
- Promoters
- Individuals and others
| Per cent | Dec 2025 | Jun 2026 | Sep 202630 Sep |
|---|---|---|---|
| 72.89% | 72.89% | 72.89% | |
| Indian promoters | 72.89% | 72.89% | 72.89% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 27.11% | 27.11% | 27.11% |
| Shares in issue | 68,60,000 | 1,71,50,000what Shares in issue, Jun 2026, includes. Bonus issue on 12 May 2026: 3 new shares for every 2 held. Earlier filings count the shares before it. | 1,71,50,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 50,00,000 | 97,79,750 | 85,06,250 |
| Promoters' shares locked in | 50,00,000 | 97,79,750 | 79,66,250 |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Aptus Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 30 Sep 2026; the largest is TEJASH MAHESHCHANDRA HATHI, 11.44%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| TEJASH MAHESHCHANDRA HATHIIndividuals and Hindu undivided families | 11.44% | 19,62,500 | 69.75% |
| KAPILBHAI HASMUKHBHAI CHANDARANAIndividuals and Hindu undivided families | 11.44% | 19,62,500 | 66.88% |
| KRIPALIBEN MAYANK THAKKERIndividuals and Hindu undivided families | 8.64% | 14,82,500 | 62.27% |
| RIDDHISH NATWARLAL TANNAIndividuals and Hindu undivided families | 8.64% | 14,82,500 | 62.39% |
| MILLY CHETAN LALSETAIndividuals and Hindu undivided families | 8.64% | 14,82,500 | 59.95% |
| GAURANG RAMESHCHANDRA THAKKERIndividuals and Hindu undivided families | 8.64% | 14,82,500 | 62.27% |
| KUNJAL PIYUSHBHAI UNADKATIndividuals and Hindu undivided families | 8.64% | 14,82,500 | 62.27% |
| GHANSHYAM VINUBHAI PANSURIYAIndividuals and Hindu undivided families | 5.31% | 9,10,000 | 63.12% |
| CHATRABHUJ VALLABHBHAI BUTANIIndividuals and Hindu undivided families | 1.47% | 2,52,500 | 50.50% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.